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Abstract 
The present study investigated the effect of substance P (SP) and protein klnase lnhlbltors (H7 and HA1004) on /3-amyloid 
peptlde-mduced proliferation of neonatal rat brain cells in primary cultures The/3-amylold peptlde I 2s (designated as/3AP28), 
at nanomolar concentrations (10 9 M), significantly (P _< 0.05) increased the proliferation of brain cells (presumably non-neuro- 
nal) as measured by [3H]thymldIne uptake into DNA (mltogenesis). The effect was dependent on t~me of culture, concentration 
of/3AP28, and presence of fetal calf serum. The supplementation of SP into cell cultures at time zero reversed the prohferatwe 
response of /3AP28. Moreover, the /3AP28-induced proliferation was inhibited by protein klnase inhibitor H7, but not by 
HAl004. Since H7 is a selective protein kinase C (PKC) inhibitor and SP action involves PKC, we conclude that /3AP28 induces 
normal brain cell proliferation through PKC pathway of cell signaling. 
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Cerebral  amyloidosis or accumulation of /3-amyloid 
protein1_40 (designated as/3AP40) in brain occurs dur- 
ing normal aging. However, the amount  of /3AP40 
increases several fold in Alzheimer 's  disease (AD), 
suggesting a pathological link of the protein with dts- 
ease [22]. The /3AP40, a small molecular weight (4 
kDa) protein containing approximately 40 amino acids 
[4], is produced by normal proteolytlc processing [14] of 
a larger precursor molecule (90 to 130 kDa) known as 
/3-amyloid precursor protein (/?APP). Both /3AP40 and 
/3AP28 fragment thereof  have been shown to induce 
neurotrophlc and neurotoxic effects on primary cul- 
tures of hippocampal cells [20,21]. Moreover,  /3AP40 
induces growth factors in glial cell cultures [1] and is 
localized extraneuronally in the skin fibroblasts [7], 
eukaryotic cultured cells [2,5] and biological fluids [13]. 
This finding suggested that /3AP40 is produced during 
normal cell metabolism presumably having a physiolog- 
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ical function throughout life. The present study de- 
scribes the effect of /3AP28 on the proliferation of 
primary brain cell cultures and its sensitivity to SP and 
protein kinase inhibitors. 
The prtmary brain cell cultures were prepared ac- 
cording to our prevtous work [15]. Sprague-Dawley  
neonatal rats (18 to 24 h old) were sacrificed under 
ether anesthesta. By using pre-sterilized dissecting 
tools, the brain was removed quickly and collected in 
RPMI-1640 growth medium. Brain ttssue was dissoci- 
ated and passed through a nylon sieve under aseptic 
conditions of a Lammar  flow-hood and the cell suspen- 
sion was passed through a 21G needle. The cell sus- 
pension was centrifuged at 800 × g for 10 min. The cell 
pellet, after one washing, was resuspended in RPMI-  
1640 containing penicdhn (100 U/ml) - s t rep tomycm 
(100 /xg/ml),  10% heat-inacttvated fetal calf serum 
(FCS) and 1% glucose. The cells were seeded into 
tissue culture flasks (25 cm 3 sxze) at a count of 2.5 × 105 
cells in 5 ml per flask and allowed to grow for 4 to 5 
days inside the humified chamber of a CO 2 (5%)-in- 
cubator at 37°C. The confluent cultures were subcul- 
tured by trypsin (0.2%) t reatment  for about 5 mln and 
2,54 I k, S t n q h ~ t a l , , B p a m R ( s e a t ( h O O O t / U o 4 )  ¢5¢ ~5( 
the cells were washed three times with RPMl-16411 
medium. They were either subcultured or used to set 
up the experiments. 
The cell proliferation was measured by [~H]thyml- 
dine uptake as described before [16]. The cell suspen- 
sion from freshly trypsmized cultures was pipetted into 
microwells of a flat-bottomed 96-well microtiter plate 
(Cornlng). Triplicate microwells were set up in the 
absence or presence of/3AP28 in a final volume of 200 
#l which Included 100/xl of cell suspension containing 
approximately 10,000 cells per well. After 5 days of 
incubation in CO?-incubator, the cells were labelled 
for 4 h with 0.4 /~C1/well of [methyt-3H]thymidine 
(spec. act. 2 Ci/mmol, purchased from NEN, Boston, 
MA) and harvested using a semi-automatic cell har- 
vester (Titertek model, Flow Labs.) onto Whatman 
glass-fiber filter paper The filter paper discs ( 10 mm in 
diameter) were transferred into counting vials, mixed 
with 2 ml of Ready Safe scintillant (Beckman) and 
counted for radioactivity using a liquid scintillation 
spectrometer (Packard Model Tri-Carb 1500) with ap- 
proximately 58% counting efficiency. The data are 
presented as the counts per minute (CPM) of radioac- 
tivity or the per cent of growth medium control. The 
statistical significance (P < 0.05) was assessed by Stu- 
dent's t-test using Statview software for the Macintosh 
computer 
Neuropeptide #AP28 (cat. #PNPE269) was a syn- 
thetic product of > 99% purity (HPLC analysis) pur- 
chased from Bachem California, Torrance, CA. Syn- 
thetic substance P (code 7451) was purchased from 
Penninsula Labs., Inc., Belmont, CA. The protein kl- 
nase inhibitors H7 (code 120805) and HA1004 (code 
120804) were purchased from Seikagaku America, St. 
Petersburg, FL. The fetal calf serum (FCS) and peni- 
cillin-streptomycin mixture were purchased from Hy- 
clone Labs. (Logan, UT) and Gibco (Grand Island, 
NY), respectively. The /3AP28 and all other reagents 
were dissolved aseptically in RPMI containing peni- 
cillin-streptomycin but no FCS and stored frozen at 
- 70°C. Whenever needed, they were thawed and used 
fresh. 
As shown in various figures, /3AP28 displayed a 
sttmulatory effect on the proliferation of brain cells in 
primary cultures. The proliferative response was signif- 
icantly higher in the presence of/3AP28 as compared 
to growth medium control (Fig. 1); the P values were 
0.003, 0.05 and 0.006 for 31 nM, 153 nM and 765 nM 
concentrations, respectively. However, it required fetal 
calf serum (FCS) since in the absence of FCS there was 
virtually no cell proliferation. The #AP28-induced cell 
proliferation increased up to 5 days of incubation that 
was used in subsequent experiments. The stimulatory 
effect of /3AP28 was observed both pre- and post-cell 
plating (Fig. 2) although the overall response was 
slightly lower if the cells had been pre-seeded overnight 
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Effect of /3AP28 on brain cell prohterat~on m pnmaly 
cultures In this experiment, 100/zl of cell suspension (approximately 
8.000 cells per mlcrowell m tnphcate) was plated in the presence or 
absence of 10% (v/v) FCS As desired, 100 /zl of growth medmm 
(blank) or a sterile solution of /3AP28 in RPM]-1640 ~as pipetted 
After 5 days, the cell proliferation was measured a~ described in the 
text The data represent mean values _+ standard error (S.E.) In the 
presence of FCS, the P values were 0 003, 005 and 0.006 at 31 nM, 
153 nM and 765 nM concentrations, respectively 
(16 to 18 h). The supplementation of substance P (SP) 
into cultures completely blocked the proliferative re- 
sponse of/3AP28 (Fig. 3). In addition, the /3AP28-in- 
duced stimulation of cell proliferation was inhibited by 
protein kinase inhibitor H7, but not by HA1004; the 
two inhibitors were tested at a concentration of 20/z M 
against the three concentrations of/3AP28 (Fig. 4). 
Based on their patholgocial link with Alzheimer's 
disease [22], the amyloid proteins of neuritic plaques 
have been intensely studied during the last decade. 
However, the pathological role of /3AP40 in AD con- 
tinues to be a matter of debate and controversy espe- 
cially in light of genetic associations of apolipoprotem 
E [12] and non-neuronal expression of/3AP40 during 
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Fig 2 Effect of time of cell plating on the prohferatwe effect ot 
/3AP28 Tnphcate cultures of approximately 10,000 cells per microw- 
ell were plated In one set up. the/3AP28 was added at tame zero (A) 
and incubated for five days Alternately, the cells were first allowed 
to differentiate (B) overmght (about 18 h), followed by the addition 
of/3AP28 and incubation for a total period of 5 days At tow to high 
concentrations of flAP28, the P values were 0 016, 0 015 and 0.0001 
for conditions under A and 0 09, < 0 0001 and 0 003 for conditions 
under B 
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Fig 3 Effect ot substance P on the action of /3AP28 The cell 
concentration was approximately 10,000 cells per mlcrowell All 
other con&t=ons of incubation were the same as those given under 
F=g 1 Whenever present, the substance P ( + SP) was at a concentra- 
tion of 20/~M The data are gJven as the per cent of control (100%) 
that did not contain /3AP28 
normal  cell metabol ism [2,5,7,13]. While a causative 
role o f / 3 A P 4 0  in A D  cont inues to be established, this 
protein may have some biological funct ion during nor- 
mal cell metabolism. This line of  thinking stems f rom 
several studies: (i) /3AP40 and its f ragment  /3AP28 
exert t rophic and toxic effects on h lppocampal  neurons  
[20,21]; ( l i ) /3AP40 expression occurs predominant ly  in 
astrocytic glial cells [2]; ( i i i ) /3AP40 occurs naturally in 
cells that  are not brain-derived [5,7,13]; (iv) /3AP40 
induces glia-derived growth factors [1]; (v ) /3AP40 elim- 
inates a functional  potassium channel  but not  calcium 
channel  in human  fibroblasts [3]; (vi) /3AP40 and 
f lAP28 induce D N A  synthesis in immunocytes  of  nor- 
mal blood donors  but not A D  patients [18]; and (vii) 
/3AP28 increases proliferat ion of  neonata l  rat brain 
cells as repor ted  in our  present  study. Since neuronal  
proliferat ion ceases early m embryogenesis  whereas  
glial cells cont inue  to divide into postnatal  periods of  
development ,  the /3AP28-induced proliferative activity 
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Fig 4 Effect  of p ro te in  klnase  lnhlbltors on /3AP28- snmula t ed  cell 
prohferatlon Three different concentrations of /3AP28 were set up 
with approximately 10,000 cells per mlcrowell Depending on design, 
the H7 or HA1004 was added at a concentration of 20 #M and the 
response was measured as described under Fig. 1 
astrocytes. Based on this considerat ion and the fact 
that  astrocytes are a major  source o f / 3 A P  in brain [2], 
we suggest that  this peptide acts as an autocrine hor- 
mone  on ghal cells and a paracrine hormone  on neu- 
rons under  physiological condit ions in vJvo. 
Our  finding of  a prol i fera t ion-enhancing effect by 
/3AP28 is similar to a neuro t rophlc  effect [20,21] but 
whether  the two involve same or  completely different 
mechanisms is not presently known One  notable dif- 
ference,  however,  is that  the proliferative response can 
be induced by 100- to 3000-fold lower concentra t ions  
of  /3AP28 than the concentra t ions  required for neu- 
rot rophic  effect: we used a concentra t ion range of  31) 
to 765 nM as compared  to 3 to 3 0 / z M  in one study [20] 
and 100 ~ M  in another  [21]. The latter study [21] 
showed that  the trophic effect o f / 3 A P 4 0  was maximal 
by approximately 0 1 nM, but /3AP28 was much less 
potent  than /3AP40 and required a 100 p,M concentra-  
tion to yield only 29% of the trophlc response Further-  
more,  the /3AP28-induced proliferative response re- 
quired serum since there was no proliferation in the 
absence of  fetal bovine serum (FCS). The reason for 
this requirment  is presently not known but we suggest 
that  /3AP28 may interact with some serum protein(s) 
ensuing a proliferative response.  Also, the morphologi-  
cal differentiat ion was not a prerequisi te since the 
st imulation of  cell proliferat ion took place irrespective 
of  the time of  addit ion (at time zero or after overnight 
seeding) o f / 3 A P 2 8  into cultures 
SP has been shown to prevent  ncuro t rophlc  and 
neurotoxic effects of  /3AP40 on hlppocampal  neurons  
[21] We also found that  SP completely reverses /3AP28 
action on cell proliferation. In contrast ,  SP did not 
modify ~2sI-/3AP40 binding to brain homogena tes  [9] or 
t runcated  /3AP22-35-1nduced neurotoxicity [19]. This 
discrepancy may be related to assay differences in 
different studies: (1) 12sI-/3AP40 binding was assayed 
with pathological  tissue (AD brain) [9] but not with 
normal  tissue and the homgena te  conta ined bovine 
serum albumin and protease  lnhlbitors (bacitracin, chy- 
mostatln,  leupeptln and dlmethyl sulfoxide) that may 
alter binding characteristics; and (ll) a t runcated 
f l A P 2 2 - 2 5  form [19], instead o f / 3 A P 4 0  o r /3AP28 ,  was 
added  to cultures after 5 days of  cell differentiat ion but 
not at time zero. Since the /3AP28-1nduced response 
was counterac ted  by SP, we suggest that  this peptide 
interacts with a molecule structurally similar to SP 
receptor  or functionally coupled to it but the nature of  
this putative molecule  remains unknown. 
Indirectly through the use of  protein kinase in- 
hlbitors, an approach  recently used by us for second 
messenger  studies of  another  neuropept ide  [17], we 
found that  the prohferat ive response of  /3AP28 was 
preferential ly inhibited by H7, a selective lnhlbltor of  
PKC [6], but  not by HA1004 which is a PKA inhibitor 
and intracellular Ca 2+ antagonist  without  any in- 
350 ~ Ix 5mglt et a / /Bram Rewar~ h 660 (/9941 353-~50 
h~bitory effect on PKC [6]. This fmding implies that the 
mechanism of proliferation-enhancing action of/3AP28 
involves a PKC-activated pathway of signal transduc- 
tlon; a mechanism strengthened by a recent study [8] 
which showed that in the presence of glutamate/3AP40 
activates tachykinin receptors and phosphattdylinositol 
(PI) turnover. PKC is a key enzyme in mediating the 
action of neurotrophic factors to maintain neuronal 
survtva] and /3AP28 certainly behaves like a growth 
factor [1,20,21, present study]. In addttion, SP, which 
prevents /3AP28-induced proliferation, also involves 
PKC-activated phosphoinositide turnover [10], indicat- 
ing that the two peptides might compete with each 
other for interaction to PKC system. Based on PKC 
involvement m /3AP28 action [present study] and PKC 
(/3II isoform) reduction in AD brains [11], we postulate 
that/3AP28 controls cellular (PKC activity) and molec- 
ular (DNA synthesis) functions of normal brain cells 
but aberration of its function at a purported site of 
action may form neuritic plaques in the CNS Thus, 
our study probes into the mechanism of cellular action 
of thts peptide which may help in understanding the 
pathological link between /3-amylold protein and 
Alzheimer's disease. 
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